In fact, IL‐21 increases the recruitment of TET2 to the BCL6 promoter region in lupus patients, while interferon (IFN)‐α, the signature cytokine for lupus, also increases AIM2 levels, albeit to a lesser degree. This evidence concerns the gene BCL6 and systemic lupus erythematosus.